Breaking News Instant updates and real-time market news.

EXAS

Exact Sciences

$45.96

0.96 (2.13%)

, ROK

Rockwell Automation

$177.55

0.22 (0.12%)

07:30
09/25/17
09/25
07:30
09/25/17
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Friday in EXACT Sciences (EXAS), Rockwell Automation (ROK), and DaVita (DVA).

EXAS

Exact Sciences

$45.96

0.96 (2.13%)

ROK

Rockwell Automation

$177.55

0.22 (0.12%)

DVA

DaVita

$57.49

-3.77 (-6.15%)

  • 30

    Nov

EXAS Exact Sciences
$45.96

0.96 (2.13%)

09/21/17
LEER
09/21/17
NO CHANGE
Target $50
LEER
Outperform
Exact Sciences price target raised to $50 from $45 at Leerink
Leerink analyst Puneet Souda raised his price target for Exact Sciences to $50 from $45 as he believes Cologuard ramp still remains under-appreciated longer-term. As part of its ongoing execution, Exact Sciencesis taking a number of steps to help accelerate the ramp and sales leverage even further, he adds, reiterating an Outperform rating on the shares.
09/07/17
ADAM
09/07/17
NO CHANGE
Target $45
ADAM
Buy
Exact Sciences remains a top pick for 2017, says Canaccord
Canaccord analyst Mark Massaro said Exact Sciences remains a top pick for 2017 after the company delivered another upbeat investor presentation. He cited the company's commentary on new hiring, its liquid biopsy development plans, and advertising spending. Massaro reiterated his Buy rating and $45 price target on Exact Sciences shares.
08/24/17
LEER
08/24/17
NO CHANGE
Target $45
LEER
Outperform
Exact Sciences poised to drive 'significant' uptake long-term, says Leerink
Leerink analyst Puneet Souda reiterates an Outperform rating on Exact Sciences given that the adoption of its Colorectal Cancer screening test Cologuard in the 80M target U.S. population remains highly underpenetrated at just about 2% with expectations to reach 30% or even more longer-term. The analyst also raised his price target on the shares to $45 from $44.
07/26/17
CHLM
07/26/17
NO CHANGE
Target $46
CHLM
Buy
Exact Sciences price target raised to $46 from $41 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich raised his price target for Exact Sciences to $46 from $41 as "exceptional" Cologuard volume drives Q2 results well above expectations, while "significant" guidance raise suggests more to come. The analyst reiterates a Buy rating on the shares.
ROK Rockwell Automation
$177.55

0.22 (0.12%)

04/04/17
WELS
04/04/17
NO CHANGE
WELS
ABB acquisition should provide support for Rockwell Automation, says Wells Fargo
Following the announcement that ABB (ABB) plans to acquire Bernecker & Rainer Industrie- Elektronik, Wells Fargo analyst Richard Kwas says the deal should provide support for Rockwell Automation's (ROK) shares, and should be a positive read through for the latter. The acquisition fills gaps for ABB in discrete automation, the analyst notes, adding that ABB could become a "more formidable competitor" in discrete. Separately, Kwas acknowledges that he had thought that Bernecker & Rainer Industrie- Elektronik may have been a "good fit" for Emerson (EMR), which he expects to execute additional M&A later in the year.
04/19/17
GABE
04/19/17
UPGRADE
GABE
Hold
Rockwell Automation upgraded to Hold from Sell at Gabelli
Gabelli upgraded Rockwell Automation to Hold with a $164 per share 2018 PMV due to strength in the consumer and automotive segments and potential M&A.
07/27/17
07/27/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Boeing (BA) was upgraded to Outperform from Neutral at Credit Suisse, to Buy from Neutral at BofA/Merrill, to Neutral from Sell at Goldman Sachs, and to Sector Perform from Underperform at RBC Capital. 2. State Street (STT) upgraded to In Line from Underperform at Evercore ISI with analyst Glenn Schorr citing improved execution and expects share to perform inline with the group despite continued fee pressure and competitive threats. 3. Vermilion Energy (VET) upgraded to Outperform from Sector Perform at RBC Capital. 4. DDR Corp. (DDR) upgraded to Buy from Hold at Deutsche Bank with analyst Vin Chao saying new management's progress towards balance sheet and disposition plans has much improved FFO visibility. 5. Rockwell Automation (ROK) upgraded to Neutral from Underweight at JPMorgan with analyst C. Stephen Tusa saying the company reported another quarter of "strong organic growth and solid fundamentals." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/27/17
JPMS
07/27/17
UPGRADE
Target $153
JPMS
Neutral
Rockwell Automation upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst C. Stephen Tusa upgraded Rockwell Automation to Neutral saying the company reported another quarter of "strong organic growth and solid fundamentals." In a research note partially titled "We Were Wrong," the analyst maintains a $153 price target for the shares.
DVA DaVita
$57.49

-3.77 (-6.15%)

06/26/17
06/26/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. GrubHub (GRUB) downgraded to Equal Weight from Overweight by Morgan Stanley analyst John Glass, who lowered his price target to $43 from $47. The firm's survey results indicate 26% of Amazon (AMZN) Prime members have tried Amazon Restaurants in the past 6 months, and other players such as UberEATS and YelpEat24 are emerging, which longer-term will reduce GrubHub's profitability and cash flow, the analyst argues. 2. Stratasys (SSYS) downgraded to Sell from Neutral by Goldman Sachs analyst Matthew Cabral, who noted that the shares are up 67% year-to-date while competition is ramping and price pressure is mounting. 3. DaVita (DVA) downgraded to Hold from Buy by Jefferies analyst Chris Cooper, who cites slowing treatment growth and the "tight" rate environment. 4. Agios Pharmaceuticals (AGIO) downgraded to Neutral by Janney Capital analyst Debjit Chattopadhyay, who believes peak sales estimates for its acute myeloid leukemia treatment are likely to move lower over time. 5. American Electric (AEP) was downgraded to Neutral from Buy while Ameren (AEE) and WEC Energy (WEC) were both downgraded to Sell from Neutral at Goldman Sachs, where analyst Michael Lapides downgraded the Utilities sector to Cautious from Neutral saying valuations now appear stretched while earnings growth appears relatively normal. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/26/17
JEFF
06/26/17
DOWNGRADE
Target $70
JEFF
Hold
DaVita downgraded to Hold from Buy at Jefferies
Jefferies analyst Chris Cooper downgraded DaVita to Hold citing slowing treatment growth and the "tight" rate environment. The analyst believes a less competitive cost base and patient steering allegations are hindering the company's rate negotiations. He sees risk to consensus estimates and keeps a $70 price target for DaVita shares.
12/13/16
12/13/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deutsche Bank analyst Bill Schmitz downgraded Procter & Gamble (PG) to Hold citing a lack of catalysts over the next few quarters. The analyst lowered his price target for P&G shares to $90 from $95 but remains positive on P&G's medium to long-term opportunity. Schmitz also downgraded Coca-Cola (KO) to Hold saying that while CEO James Quincey "is the right person for the turnaround job," near-term stock outperformance will be limited by investor migration out of staples, wellness related consumption headwinds and likely negative earnings revisions. The analyst cut his price target for Coca-Cola shares to $44 from $48. 2. Barclays analyst Karen Short downgraded GNC Holdings (GNC) to Underweight saying the company's recent strategy change and press reports indicating that at least some potential foreign buyers are not interested in the U.S. assets make a potential takeover unlikely. 3. RBC Capital downgraded Viacom (VIAB) to Underperform from Sector Perform after the company announced that it would no longer pursue a merger with CBS (CBS). Wedbush analyst James Dix also downgraded Viacom to Neutral after National Amusements withdrew support for a merger with CBS. 4. Craig-Hallum analyst Chad Bennett downgraded Model N (MODN) to Hold saying the "risks outweigh the benefits" following the company's acquisition of primary competitor Revitas. 5. Baird analyst Whit Mayo downgraded DaVita (DVA) to Neutral from Outperform after CMS issued its notice with respect to third-party premium support for ESRD patients enrolling in Exchange plans, which he views as potentially putting the company's entire $230M HIX tailwind at risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/13/16
12/13/16
DOWNGRADE
Target $69

Neutral
DaVita downgraded to Neutral after CMS guidance at Baird
As previously reported, Baird analyst Whit Mayo downgraded DaVita to Neutral from Outperform after CMS issued its notice with respect to third-party premium support for ESRD patients enrolling in Exchange plans, which he views as potentially putting the company's entire $230M HIX tailwind at risk. Mayo, who also cites the stock's 20% bounce off of its bottom and the company's "tepid" organic growth, sees DaVita shares "trading sideways" in the near-term. He raised his price target on DaVita to $69 from $68.

TODAY'S FREE FLY STORIES

MSCC

Microsemi

$51.28

-0.16 (-0.31%)

, SNPS

Synopsys

$83.72

-0.35 (-0.42%)

07:21
10/18/17
10/18
07:21
10/18/17
07:21
Conference/Events
California State University to hold a conference »

15th Annual International…

MSCC

Microsemi

$51.28

-0.16 (-0.31%)

SNPS

Synopsys

$83.72

-0.35 (-0.42%)

INTC

Intel

$39.79

0.03 (0.08%)

INFO

IHS Markit

$43.76

-0.05 (-0.11%)

LSCC

Lattice Semiconductor

$5.50

-0.07 (-1.26%)

IFX

use symbol IFNNY

QUIK

QuickLogic

$1.60

-0.05 (-3.03%)

ARMH

Acquired by SoftBank

RMBS

Rambus

MENT

Mentor Graphics

AVGO

Broadcom

$242.62

-4.05 (-1.64%)

SIE

Sierra Health Services

SOI

Solaris Oilfield

$15.88

-0.1 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 23

    Oct

  • 30

    Oct

  • 01

    Nov

  • 03

    Nov

  • 09

    Nov

  • 16

    Nov

  • 13

    Dec

  • 14

    Dec

GNRC

Generac

$50.49

-0.4 (-0.79%)

07:19
10/18/17
10/18
07:19
10/18/17
07:19
Recommendations
Generac analyst commentary  »

Generac estimates raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ADP

ADP

$113.72

-0.86 (-0.75%)

07:19
10/18/17
10/18
07:19
10/18/17
07:19
Periodicals
Ackman increases pressure on ADP over tech development, WSJ reports »

Activist investor and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 02

    Nov

PRKR

ParkerVision

$1.50

-0.06 (-3.85%)

07:19
10/18/17
10/18
07:19
10/18/17
07:19
Hot Stocks
ParkerVision enters common stock purchase agreement with Aspire Capital »

ParkerVision announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$9.23

0.15 (1.65%)

07:19
10/18/17
10/18
07:19
10/18/17
07:19
Technical Analysis
Technical View: GoPro trades higher, analyst action »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

NAVI

Navient

$12.20

0.47 (4.01%)

07:17
10/18/17
10/18
07:17
10/18/17
07:17
Hot Stocks
Navient sees adding over $1B of education refinance loans in FY17 »

Including the planned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

07:16
10/18/17
10/18
07:16
10/18/17
07:16
Conference/Events
Commodity Futures Trading Commission Commissioners to speak at Expo »

Brian Quintenz and Rostin…

FGEN

FibroGen

$55.30

0.8 (1.47%)

, AZN

AstraZeneca

$34.78

0.13 (0.38%)

07:16
10/18/17
10/18
07:16
10/18/17
07:16
Hot Stocks
FibroGen announces CFDA acceptance of roxadustat NDA »

FibroGen (FGEN) and its…

FGEN

FibroGen

$55.30

0.8 (1.47%)

AZN

AstraZeneca

$34.78

0.13 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 08

    Nov

  • 09

    Nov

CMG

Chipotle

$329.30

8.91 (2.78%)

07:16
10/18/17
10/18
07:16
10/18/17
07:16
Technical Analysis
Technical View: Chipotle falls, analyst actions »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

UNH

UnitedHealth

$203.89

10.69 (5.53%)

, AMZN

Amazon.com

$1,009.13

2.79 (0.28%)

07:16
10/18/17
10/18
07:16
10/18/17
07:16
Recommendations
UnitedHealth, Amazon.com analyst commentary  »

UnitedHealth price target…

UNH

UnitedHealth

$203.89

10.69 (5.53%)

AMZN

Amazon.com

$1,009.13

2.79 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 26

    Oct

  • 18

    Mar

AAN

Aaron's

$41.55

0.01 (0.02%)

07:15
10/18/17
10/18
07:15
10/18/17
07:15
Initiation
Aaron's initiated  »

Aaron's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

BMTC

Bryn Mawr Bank

$44.50

-0.1 (-0.22%)

, FCF

First Commonwealth

$13.94

-0.26 (-1.83%)

07:13
10/18/17
10/18
07:13
10/18/17
07:13
Conference/Events
FDIC to hold a committee meeting »

The FDIC's Advisory…

BMTC

Bryn Mawr Bank

$44.50

-0.1 (-0.22%)

FCF

First Commonwealth

$13.94

-0.26 (-1.83%)

ONB

Old National Bancorp

$18.40

-0.05 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Nov

HCC

Warrior Met Coal

$24.04

0.51 (2.17%)

07:13
10/18/17
10/18
07:13
10/18/17
07:13
Downgrade
Warrior Met Coal rating change  »

Warrior Met Coal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$61.54

1.68 (2.81%)

, UNH

UnitedHealth

$203.89

10.69 (5.53%)

07:13
10/18/17
10/18
07:13
10/18/17
07:13
Periodicals
Health insurers prepare for enrollment drop amid ACA uncertainty, WSJ says »

As enrollment for 2018…

MOH

Molina Healthcare

$61.54

1.68 (2.81%)

UNH

UnitedHealth

$203.89

10.69 (5.53%)

CNC

Centene

$93.80

2.88 (3.17%)

WCG

WellCare

$174.03

6.11 (3.64%)

CI

Cigna

$187.20

2.21 (1.19%)

ANTM

Anthem

$187.26

3.5 (1.90%)

HNT

Health Net

HUM

Humana

$240.43

3.26 (1.37%)

AET

Aetna

$155.90

4.46 (2.95%)

EHTH

eHealth

$23.79

-0.61 (-2.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 31

    Oct

  • 31

    Oct

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 08

    Nov

  • 14

    Dec

IBM

IBM

$146.54

-0.29 (-0.20%)

07:12
10/18/17
10/18
07:12
10/18/17
07:12
Recommendations
IBM analyst commentary  »

IBM reported 'best…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 15

    Nov

NVO

Novo Nordisk

$49.31

-0.01 (-0.02%)

07:12
10/18/17
10/18
07:12
10/18/17
07:12
Conference/Events
FDA Endocrinologic & Metabolic Drugs Advisory Committee to hold a meeting »

The Committee discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

TSLA

Tesla

$355.75

5.15 (1.47%)

07:11
10/18/17
10/18
07:11
10/18/17
07:11
Periodicals
Tesla employees claim dismissals not performance related, CNBC reports »

Tesla is trying to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ATTU

Attunity

$6.90

0.12 (1.77%)

07:11
10/18/17
10/18
07:11
10/18/17
07:11
Hot Stocks
Attunity's Replicate adopted by large health insurance provider »

Attunity announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

MYGN

Myriad Genetics

$35.84

-0.26 (-0.72%)

07:10
10/18/17
10/18
07:10
10/18/17
07:10
Hot Stocks
Myriad Genetics BRACAnalysis CDx sPMA by FDA for review »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

MAIN

Main Street

$40.07

-0.1 (-0.25%)

07:09
10/18/17
10/18
07:09
10/18/17
07:09
Hot Stocks
Main Street announces semi-annual supplemental cash dividend of 27.5c per share »

Main Street Capital is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

JNJ

Johnson & Johnson

$140.79

4.67 (3.43%)

07:09
10/18/17
10/18
07:09
10/18/17
07:09
Recommendations
Johnson & Johnson analyst commentary  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

IONS

Ionis Pharmaceuticals

$63.85

2.7 (4.42%)

07:09
10/18/17
10/18
07:09
10/18/17
07:09
Hot Stocks
Ionis collaborates with Seventh Sense Biosystems in blood collection device »

Ionis Pharmaceuticals has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 26

    Oct

LRCX

Lam Research

$194.55

2.19 (1.14%)

07:08
10/18/17
10/18
07:08
10/18/17
07:08
Recommendations
Lam Research analyst commentary  »

Lam Research price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMRN

Immuron

$5.03

0.1 (2.03%)

07:06
10/18/17
10/18
07:06
10/18/17
07:06
Initiation
Immuron initiated  »

Immuron initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLRX

BioLineRx

$1.09

-0.065 (-5.63%)

, RHHBY

Roche

$31.45

0.27 (0.87%)

07:05
10/18/17
10/18
07:05
10/18/17
07:05
Hot Stocks
BioLineRx: Genentech initiates Phase 1b/2 trial for BL-8040 »

BioLineRx (BLRX)…

BLRX

BioLineRx

$1.09

-0.065 (-5.63%)

RHHBY

Roche

$31.45

0.27 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

  • 30

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.